GS
BMY icon

GTS Securities’s Bristol-Myers Squibb BMY Stock Holding History

GTS Securities’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-299,500
Closed -$15.5M – 1601
2024
Q3 		$15.5M Buy
299,500
+179,400
+149% +$8.42M 0.03% 339
2024
Q2 		$4.99M Sell
120,100
-70,600
-37% -$3.16M 0.01% 861
2024
Q1 		$10.3M Buy
190,700
+45,900
+32% +$2.34M 0.02% 497
2023
Q4 		$7.43M Sell
144,800
-5,800
-4% -$304K 0.01% 765
2023
Q3 		$8.74M Buy
+150,600
New +$9.23M 0.02% 655

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GTS Securities's BMY Position: Q1 2026 in Review

GTS Securities reduced its Bristol-Myers Squibb (BMY) stake by 68% in Q1 2026, selling an estimated $767K and leaving 6,135 shares worth $372K. The position accounts for 0.01% of the portfolio, ranked #954.

GTS Securities first reported a position in BMY in Q2 2023 and has held it in 12 quarters since. The position peaked at $13.5M in Q4 2023. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • GTS Securities held 6,135 shares of Bristol-Myers Squibb worth $372K as of Q1 2026.
  • GTS Securities sold 13,152 Bristol-Myers Squibb shares in Q1 2026, an estimated $767K.
  • Bristol-Myers Squibb made up 0.01% of GTS Securities's portfolio in Q1 2026, its #954 holding.
  • GTS Securities first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 12 quarters since.
  • GTS Securities's Bristol-Myers Squibb position peaked at $13.5M in Q4 2023.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.